Use our `search` to find similar offers.
Project Scheduler 1
Charles River Laboratories International Inc (CRL)
Tranent, GB, EH33 2NE
For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
Job Summary
The Administration and Reporting department provides an efficient administrative support to study management in the running of safety assessment studies. We use various databases to ensure the effective planning, scheduling and reporting of the studies, to the standards required by the Company, its clients and international regulatory authorities.
The following are minimum requirements related to the Project Scheduler position.
- A degree or equivalent (or at least entry level to a degree qualification) in a relevant subject (e.g. Business) or significant project scheduling experience
- High degree of IT literacy, in particular, extensive experience in use of Microsoft Excel and database management.
- Excellent attention to detail, verbal and written communication skills.
- Ability to remain composed when faced with unplanned changes.
- Determination to complete jobs to tight timescales whilst maintaining a high standard.
- Ability to confidently interact with people at all levels.
- Flexible approach to working in an environment where meeting clients’ deadlines is critical.
- Commitment to the importance of quality is essential for this position
- Experience in calendar management for multiple stakeholders
- Knowledge of Good Laboratory Practice is an advantage.
Starting salary for this position is £27,163. with opportunity for progression and salary increments at regular intervals.
Closing date: 13 May 2024
About Safety Assessment Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 300 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.
About Charles River Charles River is an early-stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 17,000 employees within 90 facilities in 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2019, revenue increased to $2.62 billion.
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. We have proudly supported the development of ~85% of the drugs approved by the FDA in 2019.
Job posted: 2024-04-29
